Stocks That Hit 52-Week Lows On Friday
Friday's session saw 236 companies set new 52-week lows.
Immix Biopharma To Present Milestones Achieved To Enable Kick-Off Of 2 IMX-110 Clinical Trials At 2022 ThinkEquity Conference On October 26
Immix Biopharma, Inc. (NASDAQ:IMMX) ("ImmixBio", "Company", "We" or "Us"), a biopharmaceutical company pioneering Tissue-Specific Therapeutics (TSTx)™ targeting oncology
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's session, 78 companies made new 52-week lows.
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's trading, 517 companies set new 52-week lows.
Immatics Biotechnologies Granted U.S. Patent #11,384,129 Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=5399&f=G&l=50&d=PTXT&p=108&S1=20220712&OS=20220712&RS=20220712